Surescripts Transforms Patient Access to Specialty Drugs, Optimizing Adherence
By:
Surescripts via
Business Wire
July 27, 2022 at 08:00 AM EDT
Increased Provider Access to Real-Time Patient Information Means Greater Efficiency, Enhanced Safety and Lower Costs More prescribers and specialty pharmacists nationwide are adopting Surescripts Specialty Medications solutions to transform the manual process used to prescribe specialty medications, saving time and money for patients and providers.
“Eliminating the time-consuming and manual process of prescribing specialty medications and simplifying the delivery of patient information removes delays that threaten medication adherence,” said Frank Harvey, Chief Executive Officer of Surescripts. “It also means healthcare professionals can spend less time on paperwork and more time focused on what matters most: patients’ health.” In January 2022, Accredo specialty pharmacy implemented automation enhancements with Specialty Medications Gateway to obtain current information for a patient’s weight for use in weight-based dosing. In just two months, Accredo reported that 60% of the time the automated workflow delivered the most recent weight for the patient, creating efficiencies and reducing manual outreach. Accredo also noted that 11% of the updated weight information was of clinical significance (+/- 10% weight change) and created an opportunity for a pharmacist to review and take action to ensure patient safety through accurate dosing. “In caring for patients with complex diagnoses, specialty pharmacists must work with efficiency and quality,” said Katie Reeves, Senior Product Manager at Accredo. “Surescripts solutions accelerate the process for specialty prescribing, fulfillment and onboarding by filling information gaps with clinical intelligence. Speed and patient safety are enhanced because clean, critical clinical data is automatically delivered from the EHR with the prescription.” As of May, Accredo is reviewing more than 12,000 specialty prescriptions each month that are informed by patient clinical data that is automatically pulled directly from the electronic health record. As a result, Accredo specialty pharmacists are streamlining the inefficient manual process of enrolling patients for specialty medications and ultimately delivering improved turnaround time and patient safety. Specialty drugs account for the largest proportion of new medicines launched in the past five years, and retail prices for widely used specialty drugs increased at more than three times the rate of general inflation in 2020.
About Surescripts
View source version on businesswire.com: https://www.businesswire.com/news/home/20220727005106/en/ In May 2022, prescribers used Real-Time Prescription Benefit to save patients an average of $534.74 per specialty prescription. It’s helping patients with chronic or complex conditions get access to more affordable medications. Contacts
Media
More NewsView MoreVia MarketBeat
Tickers
DASH
Zillow’s 3-Day Rally Could Mean More Than You Think ↗
February 21, 2026
Via MarketBeat
Tickers
ZG
Hims & Hers in Free Fall: Why Analysts See Nearly 150% Upside ↗
February 21, 2026
Via MarketBeat
From Missteps to Momentum: Jack in the Box’s Comeback Plan ↗
February 21, 2026
Via MarketBeat
2026 Food Inflation Outlook: This ETF Could Outperform ↗
February 21, 2026
Recent QuotesView More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|